University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. The new funding brings the total investment from the Bill & Melinda Gates Foundation to nearly US $12 million since 2012.
The Undergraduate and Health Sciences eCalendars have been updated; browse to your faculty or school section to see what's new! This update reflects mid-year changes to undergraduate/professional programs, courses, and information for all faculties & schools. As always, academic advisors are also available to answer quesions and guide you towards academic success!
For the first time, the Postgraduate Medical Education (PGME) program and McGill Global Health Programs are distributing travel awards to medical residents! Without further due, here are our first cohort of winners. Ipshita Prakash Michael Fein Elise Vuille-Lessard Evan Wong Fadi Hamdani Han Yao Jessica Keen Kristin Popiel Congratulations to the awardees and to all applicants!
Health Sciences program, course, and university information has been successfully launched as part of the eCalendar!
Two renowned McGill University researchers are among the 14 winners of the 2014 Prix du Québec. Professor Michael Meaney, acclaimed for his achievements in the biology of child development, will be awarded the Wilder-Penfield prize. Professor Paul Lasko, a celebrated developmental biologist, will receive the Armand-Frappier award. The Prix du Québec is considered the most prestigious award attributed by the Government of Québec in cultural and scientific fields.
Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and McGill University Health Centre, is being awarded the Prix d’excellence 2014 by the Collège des médecins du Québec, for his outstanding contributions to neurogenetics and medicine. Dr. Rouleau accepts the award today at a ceremony at the Chateau Frontenac in Quebec City. TRIBUTE VIDEO: http://bit.ly/1np0tJH
Scientists from the Montreal Neurological Institute and Hospital in Canada have discovered that two genes linked to hereditary Parkinson’s disease are involved in the early-stage quality control of mitochondria. The protective mechanism, which is reported in The EMBO Journal, removes damaged proteins that arise from oxidative stress from mitochondria.